Overcoming Challenges of Somatic RNA Variant Calling in Solid Tumors
Explore techniques for accurate somatic RNA variant calling in solid tumors, addressing key challenges and improving cancer genomics analysis.
Internalizing a Comprehensive Genomic Profiling Solution with a Path to Reimbursement
Explore comprehensive genomic profiling solutions for cancer diagnosis, focusing on internalizing processes, overcoming challenges, and securing reimbursement pathways.
SNP Array Analysis of Borderline Melanocytic Tumors
Explore SNP array analysis techniques for borderline melanocytic tumors, enhancing diagnostic accuracy and treatment decisions in cancer genomics.
Developing Next Generation Biomarkers - A New Approach
Explore innovative approaches to developing next-generation biomarkers for cancer diagnosis and treatment, enhancing precision medicine and patient outcomes.
Integrative Cytogenetic and Molecular Studies Unmasks Chromosomal Mimicry in Hematologic Malignancies
Explore integrative cytogenetic and molecular studies revealing 'Chromosomal Mimicry' in hematologic malignancies, enhancing accurate diagnosis and targeted therapy for cancer patients.
Implementing ClinGen/CGC/VICC Oncogenicity Guidelines in Pediatric Variant Classification
Learn to implement ClinGen/CGC/VICC Oncogenicity Guidelines for pediatric variant classification, enhancing accuracy in cancer genomic testing and improving patient diagnosis and treatment outcomes.
Utilizing Rapid Molecular Testing to Reduce Disparities in Pediatric Cancer in Sub-Saharan Africa
Explore rapid molecular testing strategies to address pediatric cancer disparities in Sub-Saharan Africa, focusing on improved diagnosis and treatment outcomes.
Frequency and Etiology of Cytogenetically Cryptic Oncogenic Fusions in Pediatric AML
Explore cytogenetically cryptic oncogenic fusions in pediatric AML, examining their frequency and etiology to enhance diagnostic accuracy and treatment approaches.
Prognostic Significance of MYC Copy Number Gain in Large B-Cell Lymphoma - FISH Analysis
Explore the prognostic impact of MYC copy number gain in large B-cell lymphoma through FISH analysis, enhancing diagnostic accuracy and treatment decisions.
Cell-free DNA Genomic and Epigenomic Analysis to Predict Survival in mCRPC Patients
Explore genomic and epigenomic analysis of cell-free DNA to predict survival in metastatic castration-resistant prostate cancer patients undergoing AR-directed therapy.
Comparative Analysis of RNA Expression Identifies Druggable Targets in Pediatric Solid Tumors
Explore RNA expression analysis for identifying targetable therapies in challenging pediatric solid tumors, advancing precision medicine for young cancer patients.
Investigation of Pathogenic and Truncated Variants of RUNX1 and DDX41 in All of Us
Explore pathogenic and truncated variants of RUNX1 and DDX41 genes in the All of Us research program, focusing on their implications for cancer genomics and personalized medicine.
ClinGen Cancer Variant Interpretation Committee - Pilot Guidance for Somatic Cancer Variant Curation
Explore pilot guidance for somatic cancer variant curation expert panels, focusing on best practices in clinical cancer genomics and accurate patient diagnosis.
Personalized Sequencing Assays for Cerebrospinal Fluid Liquid Biopsies in Children with Brain Tumors
Explore personalized sequencing techniques for cerebrospinal fluid biopsies in pediatric brain tumor cases, enhancing diagnostic and monitoring capabilities.
A Female-Specific Chimeric RNA with Differential Expression in COVID Patients
Explore a female-specific chimeric RNA's differential expression in COVID patients, uncovering potential implications for diagnosis and treatment.
Fusion Curation Interface: An Educational Tool to Explore a Unified Framework
Explore a unified framework for representing and curating gene fusions using an educational tool designed for cancer genomics professionals.
Whole Transcriptome Sequencing as a Diagnostic Tool for AML
Explore whole transcriptome sequencing's potential as a diagnostic tool for Acute Myeloid Leukemia (AML), focusing on its applications and benefits in clinical cancer genomics.
Chromosomal Microarray Analysis for Hypocellular MDS Patients with Inconclusive Cytogenetics
Explore chromosomal microarray analysis for hypocellular MDS patients with inconclusive cytogenetics, enhancing diagnostic accuracy and treatment decisions in cancer genomics.
Mapping Variants from Multiplex Assays of Variant Effect to Human Reference Sequences
Learn to map variants from multiplex assays of variant effect (MAVEs) to human reference sequences, enhancing accuracy in clinical cancer genomics and improving patient diagnosis and treatment.
Personalized ctDNA Micro-Panels for Monitoring and Predicting Clinical Outcomes in Triple-Negative Breast Cancer
Explore personalized ctDNA micro-panels for monitoring and predicting clinical outcomes in triple-negative breast cancer patients. Gain insights into advanced genomic testing techniques.
Clinical, Cytogenetic and Genomic Profiling of B-Other Acute Lymphoblastic Leukemia - An Indian Cohort Study
Explore clinical, cytogenetic, and genomic profiling of B-Other Acute Lymphoblastic Leukemia in an Indian cohort study. Gain insights into cancer genomics and its impact on accurate diagnosis and treatment.